Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver; More than triple capacity.
Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver; More than triple capacity. Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver New GMP (good manufacturing practice) facility to meet increasing demand for lipid nanoparticle (LNP) development and clinical drug product manufacturing Evonik invests over 150 million CAD (93 million EUR) ...